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ABSTRACT
The basal forebrain (BF) plays an important role in modulating cortical activity and facili-
tating processes of attention, learning, and memory. This role is subserved by cholinergic neurons
but also requires the participation of other noncholinergic neurons. Noncholinergic neurons
include -amino butyric acidergic (GABAergic) neurons, some of which project in parallel with the
cholinergic cells to the cerebral cortex, others of which project caudally or locally. With the
original aim of distinguishing different subgroups of GABAergic neurons, we examined immu-
nostaining for the calcium binding proteins (CBPs) parvalbumin (Parv), calbindin (Calb), and
calretinin (Calret) in the rat. Although the CBP cell groups were distributed in a coextensive
manner with the GABAergic cells, they were collectively more numerous. Of cells retrogradely
labeled with cholera toxin (CT) from the prefrontal or parietal cortex, Parv and Calb cells, but
not Calret cells, represented substantial proportions (35–45% each) that collectively were
greater than that of GABAergic projection neurons. From dual immunostaining for the CBPs and
glutamic acid decarboxylase (GAD), it appeared that the vast majority (90%) of the Parv group
was GAD, whereas only a small minority (10%) of the Calb or Calret group was GAD.
Significant proportions of Calb (40%) and Calret (80%) neurons were immunopositive for
phosphate-activated glutaminase, the synthetic enzyme for transmitter glutamate. The results
suggested that, whereas Calret cells predominantly comprise caudally or locally projecting,
possibly glutamatergic BF neurons, Parv cells likely comprise the cortically projecting GABAer-
gic BF neurons and Calb cells the cortically projecting, possibly glutamatergic BF neurons that
would collectively participate with the cholinergic cells in the modulation of cortical activity. J.
Comp. Neurol. 458:11–31, 2003. © 2003 Wiley-Liss, Inc.
Indexing terms: calcium binding proteins; medial septum–diagonal band; substantia innominata;
preoptic nuclei
The basal forebrain (BF) plays a critical role in the
modulation of cortical activity across sleep–wake states
(for review, see Jones, 2000). Constituent cholinergic neu-
rons stimulate cortical activation during waking and par-
adoxical sleep and play an important role in the processes
of attention, learning, and memory (Metherate et al.,
1988, 1992; Smith, 1988; Huerta and Lisman, 1993; Jones,
1993; Muir et al., 1994; Kilgard and Merzenich, 1998;
Cape and Jones, 2000; Cape et al., 2000). In addition to
cholinergic cells, other neurons constitute important ele-
ments of the BF cell population. Among these, -amino
butyric acidergic (GABAergic) neurons are twice as nu-
merous and more heterogeneous than the cholinergic neu-
rons (Brashear et al., 1986; Kiss et al., 1990a; Gritti et al.,
1993). Relatively small GABAergic neurons project cau-
dally and most probably locally (Gritti et al., 1994) to
the diencephalon and brainstem, and relatively large
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GABAergic neurons project in parallel with the cholin-
ergic neurons to the cerebral cortex (Gritti et al., 1997).
Subgroups of GABAergic neurons projecting to different
targets may play different roles in the modulation of cor-
tical activity and behavioral state (for review, see Jones
and Muhlethaler, 1999). Multiple subgroups of GABAergic
neurons have been distinguished by their morphology,
projections, and physiology in the neocortex and hip-
pocampus. These have also been found to differ in their
content of the calcium binding proteins (CBPs) parvalbu-
min (Parv), calbindin-D28k (Calb), and calretinin (Calret)
that has accordingly provided a means to distinguish
them by immunohistochemical staining (Celio, 1986;
Kawaguchi and Hama, 1988; Kawaguchi and Kubota,
1993; Freund and Buzsaki, 1996; DeFelipe, 1997). In the
neocortex and hippocampus, these CBPs are contained
within largely nonoverlapping groups of nonpyramidal
GABAergic interneurons. Within the BF of the rat, the
CBPs have been visualized in noncholinergic, presumed
GABAergic neurons (Celio, 1990; Kiss et al., 1990a, 1997;
Chang and Kuo, 1991; Zaborszky et al., 1999). In the
medial septum–diagonal band nuclei, Parv-containing
neurons have been shown to correspond to the septohip-
pocampal projection GABAergic neurons (Freund, 1989;
Kiss et al., 1990b), whereas Calret-containing neurons
appeared to correspond to locally or caudally projecting
presumed GABAergic neurons (Kiss et al., 1997). The
CBPs thus appeared to be a useful tool for identifying and
distinguishing different subgroups of noncholinergic, pre-
sumed GABAergic neurons in the BF.
The original aims of the present study were to deter-
mine in the rat brain whether the CBPs are contained
within subgroups of GABAergic BF neurons and to inves-
tigate which CBP(s) is(are) contained within the cortically
projecting GABAergic neurons. With immunoperoxidase
staining, we examined the distribution of all Parv-, Calb-,
and Calret-immunostained neurons and the distribution
of those projecting to the prefrontal or parietal cortex
visualized by retrograde transport of cholera toxin (CT).
Given unanticipated larger numbers of CBP-containing
neurons as compared with GABAergic neurons (Gritti et
al., 1993, 1997) in estimated total and cortically projecting
cell contingents, we subsequently examined the colocaliza-
tion of the CBPs with the synthetic enzyme for GABA, glu-
tamic acid decarboxylase (GAD), by dual-immunofluorescent
staining. We also investigated whether Calb might be colo-
calized with choline acetyl transferase (ChAT) in the rat
brain, as documented in the monkey brain (Chang and Kuo,
1991). We also examined whether CBPs might be colocalized
with glutamate by dual immunostaining for phosphate
activated glutaminase (PAG), the synthetic enzyme for
the transmitter pool of glutamate (Kaneko and Mizuno,
1988, 1994; Akiyama et al., 1990; Kaneko et al., 1992;
Manns et al., 2001). We previously presented some of the
results in abstract form (Gritti et al., 1999, 2001).
MATERIALS AND METHODS
Animals and surgery
Fourteen adult male Wistar rats (Charles River, St.
Constant, Canada), weighing approximately 250 g were
used in this study. The rats were anesthetized with so-
dium pentobarbital (Somnotol, 60–67 mg/kg, intraperito-
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AAA anterior amygdaloid area
ac anterior commissure
Acb nucleus accumbens
AHA anterior hypothalamic area
AM anteromedial thalamic nucleus
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BLA basolateral amygdaloid nucleus
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f fornix
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ic internal capsule
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IMD intermediodorsal thalamic nucleus
LH lateral hypothalamic area
LHa anterior lateral hypothalamic area
LO lateral orbital cortex
LOT lateral olfactory tract nucleus
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LS lateral septum
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POAH preoptic-anterior hypothalamic region
PT paratenial thalamic nucleus
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Re reuniens thalamic nucleus
Ret reticular thalamic nucleus
Rh rhomboid thalamic nucleus
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SIa substantia innominata pars anterior
SIp substantia innominata pars posterior
sm stria medullaris
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neally) for all surgical procedures and for perfusion. The
McGill University Animal Care Committee and the Cana-
dian Council on Animal Care approved all procedures.
For the study of the CBP-containing cells that project to
the cerebral cortex with the use of immunoperoxidase
techniques, eight rats were first operated on under gen-
eral anesthesia for injection of the retrograde tracer, CT b
subunit (choleragenoid; LIST Biological Laboratories,
Campbell, CA). The tracer was placed into the prefrontal
cortex in four rats (CT22, CT25, CT26, and CT27) and into
the parietal cortex in four rats (CT24, CT29, CT30, and
CT31). Injections were performed under stereotaxic guid-
ance according to coordinates for the right prefrontal cor-
tex: anterior–posterior (AP), 11.5; vertical (V), 5.5; lat-
eral (L), 0.75 (with reference to ear bar zero); and for the
right parietal cortex: AP, 1.0; V, 3.0; L, 4.6 (with
reference to bregma; see Paxinos and Watson, 1986). CT
was dissolved as a 1% solution in Tris buffer (pH 7.5) and
injected in a volume of 100 nl over 5–10 minutes through
a 1-l Hamilton microsyringe that was fitted with an
oil-filled micropipette with a tip diameter of 50–100 m.
Two rats (CT22 and CT24) also received colchicine treat-
ment approximately 24 hours after the CT injections and
approximately 24 hours before death. All rats were killed
under anesthesia by perfusion with a paraformaldehyde
fixative approximately 48 hours after the CT injections.
For the study of the colocalization of CBPs and the
transmitter enzymes using immunofluorescent staining,
six rats were used (CT80, CT81, CT82, CT83, PP1, and
PP2), four of which (CT80, CT81, CT82, CT83) received
colchicine treatment approximately 24 hours before death
and were killed under anesthesia by perfusion with a
Zamboni fixative.
As previously described (Gritti et al., 1997), colchicine
(Sigma, St. Louis, MO) was injected in a dose of 50 g in
25 l of saline solution into the left ventricle of anesthe-
tized rats according to stereotaxic procedures (coordinates
AP 0.8, V 4.4, L 1.5, with reference to bregma).
Colchicine was found to enhance GAD immunostaining
within nerve cell bodies but to not alter that of CBPs for
which it was deemed unnecessary. Although it was also
found to be unnecessary for revealing GAD when using
the anti-GAD67 antibody in paraformaldehyde-fixed tis-
sue (Gritti et al., 1997), colchicine was important for re-
vealing GAD with this antibody in the Zamboni-fixed tis-
sue used for the immunofluorescent staining of PAG.
Perfusion and fixation
Brains used for immunoperoxidase staining of CBP and
CT (from eight rats) were fixed with a paraformaldehyde
solution. After a brief rinse with phosphate buffered saline
(0.1 M, containing 20 mM MgCl2, pH 7.4), the animals
were perfused through the ascending aorta with 1,000 ml
of 3% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4
over 30 minutes), followed by 10% sucrose in phosphate
buffer (pH 7.4, over15 minutes), as previously described
(Gritti et al., 1993, 1997). The brains were removed and
immersed overnight in 30% sucrose in phosphate buffer
for cryoprotection. Brains were subsequently frozen at
50°C with isopentane and stored at 80°C.
Brains used for immunofluorescent staining of CBP and
GAD, PAG, or ChAT (from six rats) were fixed with Zam-
boni’s solution, according to a slight modification of the
procedure developed by Kaneko and colleagues for immu-
nostaining of the PAG enzyme (Kaneko and Mizuno, 1988;
Kaneko et al., 1989; Manns et al., 2001). After a brief rinse
with phosphate buffered saline, the animals were per-
fused through the ascending aorta with 500 ml of a mod-
ified Zamboni’s solution containing 0.3% paraformalde-
hyde and 75% saturated picric acid in 0.1 M sodium
phosphate buffer (pH 7.0, over 30 minutes). The brains
were postfixed overnight at 4°C in a solution of 3% para-
formaldehyde with 75% saturated picric acid. Brains were
subsequently immersed in a solution of 30% sucrose at 4°C
for approximately 48 hours for cryoprotection. Brains
were then frozen at 50°C and stored at 80°C.
Immunohistochemistry
Immunoperoxidase staining. Brains processed for
immunoperoxidase staining (by L.M.) of CBP and CT were
cut in the coronal plane on a freezing microtome at a
thickness of 25 m (CT22 and CT24) or 20 m (CT25,
CT26, CT27, CT29, CT30, and CT31). Sections were col-
lected at 400-m intervals in phosphate buffer (pH 7.4, 0.1
M) to produce 16 or 20 adjacent series.
With the peroxidase–antiperoxidase (PAP) technique
employed previously (Gritti et al., 1997), adjacent series
from several brains were processed for single or dual im-
munostaining of the CBPs and CT. Single-immunostained
series were processed for Parv (CT22, CT24, and CT25),
Calb (CT22, CT24, and CT25), or Calret (CT29 and CT30).
For Parv, a monoclonal antibody from mouse (Sigma) was
used at a dilution of 1:1,000; for Calb, a monoclonal anti-
body from mouse (Sigma) was used at a dilution of 1:200;
and for Calret, a polyclonal antibody from rabbit (Chemi-
con International, Temecula, CA) was used at a dilution of
1:10,000. Sections were incubated in the primary antibod-
ies overnight at room temperature. They were subse-
quently placed for 30 minutes in an anti-mouse (for Parv
and Calb) or anti-rabbit (for Calret) secondary antibody
(both from donkey, diluted 1:50 or 1:100, respectively;
Jackson Immuno Research, West Grove, PA) and then for
30 minutes in mouse or rabbit PAP (diluted 1:200; Jack-
son Immuno Research). PAP was revealed by 3, 3-
diaminobenzidine (DAB) in the presence of 0.1% glucose
oxidase for 14 minutes at room temperature. Adjacent
series of sections were processed with sequential, dual-
immunoperoxidase staining for CT and one CBP, accord-
ing to previously published procedures (Gritti et al., 1994,
1997). Sections were incubated overnight in goat anti-
choleragenoid antiserum (at a dilution of 1:40,000; LIST
Biological Laboratories). They were subsequently placed
in an anti-goat antiserum (from donkey at 1:100) and goat
PAP (1:200; both from Jackson Immuno Research). PAP
was revealed with DAB using nickel intensification in the
presence of 0.01% H2O2 for 6 minutes or in the presence of
0.1% glucose oxidase for 15 minutes (in CT22 and CT24).
After prolonged rinsing, series of sections were incubated
for dual immunostaining with one of the CBP antibodies:
the mouse antibody for Parv (1:1,000; in all brains), the
mouse antibody for Calb (1:200; in CT22, CT24, CT25,
CT26, CT27, and CT31), or the rabbit antiserum for Calret
(1:10,000; in CT29 and CT30), as described above. PAP
was revealed by using DAB in the presence of 0.1% glucose
oxidase in Tris buffer (pH 7.4) for 13–15 minutes at room
temperature.
In all single- or dual-immunoperoxidase staining proce-
dures, a Tris saline solution (TS; 0.1 M) containing normal
donkey serum at 1% concentration was used for diluting
the primary antibody and for rinsing, and one containing
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normal donkey serum at 6% was used for blocking before
incubations. Controls were routinely run with every pro-
cedure by omitting the primary antibodies and for anti-
sera, replacing them with normal sera from the same
species to ensure that nonspecific staining due to cross-
reactivity was not occurring. At the end of processing, all
sections were washed in phosphate buffer, mounted out of
water, dehydrated, and coverslipped with Permount
(Fisher Scientific, Fairlawn, NJ).
Immunofluorescent staining. To assess dual immu-
nostaining for the CBPs and GAD, PAG, or ChAT enzyme
proteins (EPs), we found that immunoperoxidase tech-
niques were not suitable due to the colocalization of the
CBPs and EP in the cytoplasm of the cells and thus used
immunofluorescent staining (by L.M. and I.D.M.) in six
brains (CT80, CT81, CT82, CT83, PP1, and PP2). Sections
were cut on a freezing microtome at 20 m thickness, and
20 adjacent series of sections were collected at 400-m
intervals.
Dual immunostaining for CBPs and GAD was per-
formed in series from four brains (CT80, CT81, CT82, and
CT83). For Parv or Calb with GAD, series of sections were
incubated overnight at room temperature with the mouse
anti-Parv (1:1,000) or mouse anti-Calb (1:200) antibodies
in conjunction with a rabbit polyclonal antibody for
GAD67 (1:3,000; Chemicon International). The sections
were subsequently incubated for 2 hours with a Cy2-
conjugated anti-mouse antiserum (1:200) for revelation of
the Parv or Calb and with a Cy3-conjugated anti-rabbit
antiserum (1:1,000) for revelation of the GAD enzyme
(both secondary antibodies were from goat and supplied
by Jackson Immuno Research). Similarly, the dual immu-
nostaining of Calret with GAD was performed by incubat-
ing sections overnight in the rabbit anti-Calret antiserum
(1:10,000) with a sheep anti-GAD antiserum (1:1,000; sup-
plied by E. Mugnaini, Chicago, IL; Oertel et al., 1982).
These sections were then incubated with Cy2-conjugated
anti-rabbit antiserum (1:50) for revelation of the Calret
and a Cy3-conjugated anti-sheep antiserum (1:1,000) for
revelation of the GAD enzyme (both secondaries from
donkey; Jackson Immuno Research).
Dual immunostaining for CBPs with PAG (in series
from CT80, CT81, CT82, CT83, PP1, and PP2) was per-
formed by incubating adjacent series of sections with an-
tibodies to the respective CBPs in conjunction with a rab-
bit anti-PAG antiserum (1:6,000, developed and kindly
supplied by T. Kaneko, Kyoto, Japan; Akiyama et al.,
1990). The sections were incubated in the mouse anti-Parv
antibody (1:1,000) with the rabbit anti-PAG antibody (1:
6,000) and subsequently in a biotinylated anti-mouse sec-
ondary antibody (1:1,000) followed by Cy2-conjugated
streptavidin (1:1,000) for Parv with a Cy3-conjugated
anti-rabbit antiserum (1:1,000) for PAG (both secondary
antibodies were from donkey and supplied by Jackson
Immuno Research). In another series, sections were incu-
bated with the mouse anti-Calb antibody (1:200) with the
rabbit anti-PAG antibody, followed by a Cy2-conjugated
anti-mouse antiserum (1:200) for revelation of Calb and a
Cy3-conjugated anti-rabbit antiserum (1:1,000) for revela-
tion of PAG (both secondary antibodies were from goat;
Jackson Immuno Research). Dual immunostaining of Cal-
ret with PAG was performed by incubating an adjacent
series of sections with a goat polyclonal antibody for Cal-
ret (1:2,500; Chemicon International) and rabbit anti-PAG
(1:6,000). The sections were subsequently incubated with
biotinylated anti-goat antiserum (1:50) followed by a Cy2-
conjugated streptavidin (1:1,000) for revelation of Calret
and a Cy3-conjugated anti-rabbit antiserum (1:1,000) for
revelation of PAG (with both secondaries from donkey;
Jackson Immuno Research).
Dual immunostaining for Calb with ChAT was per-
formed in two brains (CT81 and CT82) by incubating
sections with the mouse anti-Calb antiserum (1:200) and a
rabbit anti-ChAT antiserum (1:3,000; Chemicon Interna-
tional). The sections were subsequently incubated with
Cy2-conjugated anti-mouse antiserum (1:200) for revela-
tion of Calb and a Cy3-conjugated anti-rabbit antiserum
(1:1,000) for revelation of the ChAT enzyme (both second-
aries were from goat; Jackson Immuno Research).
For all series of immunofluorescent staining, the pri-
mary and secondary antibodies were diluted in TS (0.1 M,
pH 7.4) that contained 1% bovine serum albumin and was
also used for rinses between incubations. Before incuba-
tion with the primary antibody, the sections were placed
in TS with 6% bovine serum albumin for blocking. Con-
trols were routinely run with every dual-immunostaining
procedure by omitting the primary antibodies and for an-
tisera, replacing them with normal sera from the same
species. At the end of processing, all sections were washed
in TS, mounted from TS, dehydrated, and coverslipped
with Permount (Fisher Scientific).
Analysis
Immunoperoxidase material. For the analysis of
immunoperoxidase-stained material (performed by I.G.), a
computer-based two-dimensional image analysis system
(Biocom, Les Ulis, France) was employed. It comprised a
Leitz Orthoplan microscope equipped with an x-/y-
sensitive stage and video camera connected to a Compaq
386 computer. For assessment of CT injection sites, the
region of the deposit in the cortex was outlined, and the
retrogradely labeled neurons were mapped in the cortex
and thalamus. For morphologic and numerical assess-
ments of CBP-immunopositive () and CT cells in the
BF, cells were drawn or plotted through the basal fore-
brain cholinergic cell area. For this purpose, a previously
designed and published computer atlas (Gritti et al., 1993)
was used that allowed fitting of each section to the atlas
and plotting of cells into the contours of the cytoarchitec-
tonically and immunohistochemically delineated nuclei of
the BF at six levels (separated by 800 m) from A10.9 to
A6.9 (with reference to Paxinos and Watson, 1986). For
mapping, all profiles of nerve cell bodies that were immu-
nopositive were plotted (by using a 40	 objective) through
the entire area of each nucleus at each level (Gritti et al.,
1993). For measurement of cell soma length, nerve cell
bodies were selected at relatively equally spaced intervals
through the full area of each nucleus and drawn in contour
by using a 40	 objective. In those series dual immuno-
stained for CBPs and CT, cells were drawn or plotted as
CBP/CT immunopositive or immunonegative to compute
averages or totals for the CBP and CT cell groups. Accord-
ingly, cells were classified as: Parv/CT, Calb/CT, or
Calret/CT; Parv/CT, Calb/CT, or Calret/CT; or
Parv/CT, Calb/CT, or Calret/CT.
Total cell counts were computed per nucleus in one
brain for single-labeled CBP cell types and in multiple
brains (three or four) for double-labeled CBP/CT cell
types. The estimated total numbers of cells were calcu-
lated according to Abercrombie’s (1946) formula by multi-
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plication of the raw cell counts by the number of sections
per interval and by a correction factor for cell size (mean
large diameter) in relation to section thickness, i.e., sec-
tion thickness (m)/(section thickness [m]  cell diame-
ter [m]), calculated per nucleus in the same manner
performed previously for estimation of GAD and ChAT
cell numbers (Gritti et al., 1993, 1994, 1997).
Immunofluorescent material. For assessment of
dual-immunostaining for CBP and the EPs, GAD, PAG, or
ChAT, series of sections were examined (by I.D.M.) under
fluorescent illumination for double labeling of the CBP
cells with the EP. The sections were examined with a Leitz
Dialux EB20 microscope equipped with a Ploemopak 2
reflected light fluorescence illuminator and Leica filter
cubes for fluorescein (I3 with excitation between 450 and
490 nm and long pass emission above 515 nm) and rhoda-
mine (N2.1 with excitation between 515 and 560 nm and
long pass above 590 nm). Because the fluorescent images
could not be transmitted by video camera and mapped
with our image analysis system (as for the immunoperox-
idase material), fluorescent cells were examined under the
microscope by using a 63	 oil objective and their single or
dual immunostaining was tabulated by hand. In each
microscopic field, all CBP cell body profiles were evalu-
ated for double labeling with the respective EPs (EP).
Because of fewer labeled cells due to lower sensitivity in
immunofluorescence than in immunoperoxidase material,
cells were examined on all sections of each series. By
progressing systematically through the nuclei (except the
olfactory tubercle) of the BF, CBP cell body profiles were
accordingly judged as EP or EP and tabulated per mi-
croscopic field starting at A10.9 and moving caudally to
A6.9 at 400-m intervals through the BF nuclei (to
yield  60–160 profiles sampled for the different series
across nuclei). Three series were examined for the CBPs
dual immunostained with GAD or PAG, and two series
were examined for Calb with ChAT. Results were tabu-
lated for calculation and presentation of the average pro-
portion of the respective CBP cells examined that were
GAD, PAG, or ChAT.
Statistical analysis was performed with Systat 9.0
(SPSS, Chicago, IL). Color photographs were prepared
with Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA).
Atlas diagrams (from Biocom) were prepared as composite
illustrations with Corel Draw 8.0 (Ottawa, Canada).
RESULTS
Distribution of CBP-containing neurons
Through the cholinergic cell area of the BF, where cho-
linergic and GABAergic cells are codistributed, there were
neurons containing the CBPs Parv, Calb, or Calret. The
CBP cells were of different sizes and shapes, from small
to large and oval, fusiform, or polygonal (Fig. 1A,C,E). The
Parv BF cells often were multipolar in shape and ap-
peared to be commonly and relatively large in size (Fig.
1A; with a maximum large diameter of 29.6 m and
mean 
 standard deviation of 16.9 
 3.7 m; Table 1).
Calb BF cells were highly variable in shape and size but,
in addition to many small cells, included relatively large
multipolar cells (Fig. 1C; with a maximum large diameter
of 27.7 m and 14.8 
 3.6 m; Table 1). The Calret BF
cells also were variable, often oval or fusiform and bipolar
(Fig. 1E) and, in addition to many small or medium cells,
included some large cells (with a maximum large diameter
of 25.8 m and 15.5 
 3.7 m; Table 1).
Through the BF, the CBP cell groups were distributed
throughout the cholinergic cell nuclei (Figs. 2, 3, 4), where
they appeared to be more numerous than GAD cells
(Gritti et al., 1993). According to estimates of total num-
bers of cells in one brain (Table 1), Parv (23,000), Calb
(72,000), and Calret (27,000) cells greatly outnum-
bered GAD and ChAT cells in the BF nuclei (estimated
at 39,000 and 18,000 according to similar calculations
by Gritti et al., 1993). This also was the case with the
exclusion of cells in the olfactory tubercle, where many
small Calb cells are located, for BF totals of 18,243
Parv, 34,690 Calb, 22,527 Calret, 30,791 GAD; and
15,056 ChAT.
Distribution of cortically projecting
CBP-containing neurons
To determine whether the different CBP-containing cell
groups comprised cortically projecting neurons, retro-
grade labeling with CT was examined in CBP neurons by
dual immunostaining using immunoperoxidase in brains
with CT injections into the prefrontal or parietal cortex.
CT injection sites. The position and extent of the CT
injections in the prefrontal and parietal cortices were as-
sessed by the CT deposit in the cortex (Fig. 5) and then by
the distribution of retrogradely labeled projection neurons
in the contralateral cortex and in the ipsilateral thalamus
within each brain, as previously documented (Gritti et al.,
1997).
Injections were centered in the medial prefrontal cortex
in four rats. The CT deposit was commonly located in the
medial/ventral orbital cortex (MO/VO) and extended into
the prelimbic cingulate cortex, area 3 (Cg3), more dorsally
(Fig. 5A), similarly to previously published prefrontal cor-
tex injection sites (Gritti et al., 1997). Across rats the
injection sites also overlapped to varying degrees into the
ventrolateral orbital (VLO) cortex laterally (CT25 and
CT26), the infralimbic (IL) cortex caudally (CT25 and
CT26) and the prelimbic cingulate cortex, area 1 (Cg1),
cortex dorsally (CT27). Retrogradely labeled corticocorti-
cal projection neurons were located in the contralateral
homotypic cortex, including MO/VO (CT22, CT25, CT26,
and CT27), VLO (CT25 and CT26), Cg3 (CT22, CT25,
CT26, and CT27), IL (CT25 and CT26), and Cg1 (CT27).
Retrogradely labeled thalamocortical projection neurons
were commonly located in the mediodorsal nucleus (MD),
the centrolateral nucleus (CL), and the midline, reuniens
(Re), and rhomboid (Rh) nuclei. A few retrogradely labeled
neurons were also observed in different animals in the
paratenial (PT), paraventricular (PV), centromedial (CM),
paracentral (PC), anteromedial (AM), interanteromedial
(IAM), intermediodorsal (IMD), and ventromedial (VM)
nuclei.
Injections were centered in the parietal cortex in four
rats. The CT deposit was located over the primary somato-
sensory cortex, parietal cortex 1 (Par1, Fig. 5B), similarly
to previously published parietal cortical injection sites
(Gritti et al., 1997). All injections (CT24, CT29, CT30, and
CT31) were centered in the dorsomedial region of Par1.
The retrogradely labeled corticocortical projection neu-
rons were located predominantly in the contralateral ho-
motypic Par1 cortex. In all rats, the retrogradely labeled
thalamocortical neurons were located predominantly in
the ventroposterior lateral and medial nuclei (VPL and
15PARVALBUMIN, CALBINDIN, OR CALRETININ
VPM) and in the posterior (PO), centromedial (CM), cen-
trolateral (CL), and PC (paracentral) nuclei.
Retrogradely labeled CBP neurons. Across the BF
cholinergic cell area, CBP cells were retrogradely labeled
with CT from the prefrontal cortex and the parietal cortex
(Fig. 1). Substantial numbers of Parv/CT cells were
retrogradely labeled and often darkly labeled with many
prominent CT granules in their soma (Fig. 1B). Simi-
larly, many Calb/CT cells were retrogradely labeled
and often darkly so, indicating many prominent CT
granules (Fig. 1D). Very few Calret cells could be found
that were retrogradely labeled, and these were very
lightly labeled, indicating small numbers of light CT
granules (Fig. 1F). Given their rarity and minimal label-
Fig. 1. Photomicrographs of sections taken through the basal fore-
brain (BF) cholinergic cell area and processed by immunoperoxidase
staining for parvalbumin (Parv), calbindin (Calb), or calretinin (Cal-
ret) by single immunostaining (A, C, E) or for Parv and cholera toxin
(CT), Calb-CT, or Calret-CT by dual immunostaining (B, D, F) by
using 3, 3-diaminobenzidine (DAB) for the calcium binding proteins
(CBPs) and DAB with nickel intensification for CT. The retrograde
labeling is evident by the darkly stained CT granules in the soma (B,
D, F). Images are taken from the region of the magnocellular preoptic
nucleus and substantia innominata pars anterior (near the perforat-
ing blood vessels seen in A, C, and E; near A8.5, Figs. 2–4) to show
single- (A, C, E) and dual- (B, D, F) immunostained CBP and CBP/
CT cells, respectively (Parv and Parv/CT cells; Calb and Calb/
CT cells; and Calret and Calret/CT cells). Scale bars  20 m.
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Fig. 2. Computer-based atlas figures of the basal forebrain cholinergic cell area (Gritti et al., 1993) in
which parvalbumin-immunopositive neurons were plotted. Each symbol marks one labeled cell. For
abbreviations, see Abbreviations list.
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Fig. 3. Computer-based atlas figures of the basal forebrain cholinergic cell area in which calbindin-
immunopositive neurons were plotted. Each symbol marks one labeled cell. For abbreviations, see
Abbreviations list.
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Fig. 4. Computer-based atlas figures of the basal forebrain cholinergic cell area in which calretinin-
immunopositive neurons were plotted. Each symbol marks one labeled cell. For abbreviations, see
Abbreviations list.
20 I. GRITTI ET AL.
ing, the Calret/CT cells were not considered to repre-
sent a significant group of cortically projecting cells and
thus were not systematically studied. Clearly represent-
ing significant numbers of retrogradely labeled cells, all
Parv/CT and Calb/CT cells were mapped and tabu-
lated in multiple brains with CT injections in the prefron-
tal or parietal cortex.
In the BF, Parv and Calb cells, which were retro-
gradely labeled from the prefrontal cortex or the parietal
cortex, appeared similar in size. As for the total group of
Parv cells, the Parv/CT cells were often polygonal and
relatively large (Fig. 1B; with average large diameter of
17.3
 4.0 m from prefrontal cortex; Table 1). Calb/CT
cells also were often polygonal and relatively large (Fig.
1D; with average large diameter of 16.5 
 3.1 m from
prefrontal cortex; Table 1). These cortically projecting
CBP cells did not appear to differ significantly in shape
or size from cortically projecting GAD or ChAT cells
according to measurements in our previous studies (with
mean large diameters of 17.7
 3.9 m and 19.1
 3.9 m,
respectively; Gritti et al., 1997). The BF CBP/CT cells
retrogradely labeled from the prefrontal (Figs. 6, 7) or
parietal (Figs. 8, 9) cortex were intermingled with CBP/
CT cells and collectively distributed throughout the BF
in a manner similar to previously published maps of basal
cortical projection neurons (Gritti et al., 1997). With
CBP/CT cells, the Parv/CT and Calb/CT cells com-
prised neurons that were lightly labeled (with 5 to
10–15 CT grains) in addition to those that were darkly
labeled (with 10–15 CT, often prominent, grains; Figs.
6–9), which were tabulated together. The variation in the
degree of retrograde labeling from dark to light was inter-
preted, as in our previous study, as reflecting the different
densities of terminal innervation in the cortical target
area by individual cells. Within the broader, overlapping
distributions of retrogradely labeled neurons, darkly ret-
rogradely labeled neurons from prefrontal as opposed to
parietal cortex were clustered in different subregions of
the BF, as previously noted (Gritti et al., 1997).
From the prefrontal and parietal cortexes, numerous BF
Parv/CT, Calb/CT as well as Parv/CT and Calb/
CT neurons were retrogradely labeled (Figs. 6–9). The
total number of retrogradely labeled cells and their appor-
tionment across nuclei differed slightly across animals as
a function of the variation in injection site placement. In
addition, however, more retrogradely labeled cells were
Fig. 5. Images of cholera toxin subunit b injection sites in the
prefrontal cortex (A; A12.7) and parietal cortex (B; A9.7) taken
from representative cases. The injection in the prefrontal cortex in-
cluded the medial–ventral orbital cortex (MO/VO) and area 3 of the
cingulate cortex (Cg3). In the parietal cortex, the injection was situ-
ated in the dorsomedial region of area 1 (Par1) of the somatosensory
cortex. For other abbreviations, see Abbreviations list. Scale bar  1
mm.
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Fig. 6. Computer-based atlas figures of the basal forebrain (BF)
cholinergic cell area on which parvalbumin-immunopositive (Parv)
and other neurons that were retrogradely labeled with cholera toxin
subunit b (CT) from the prefrontal cortex were mapped in a repre-
sentative case. Parv/CT neurons (triangles) and Parv/CT neu-
rons (crosses) are codistributed throughout the BF. Darkly retro-
gradely labeled cells (CT, solid symbols and thick crosses) are
distinguished from lightly retrogradely labeled cells (CT, open sym-
bols and thin crosses). Each symbol marks one labeled cell. For ab-
breviations, see Abbreviations list.
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Fig. 7. Computer-based atlas figures of the basal forebrain (BF)
cholinergic cell area on which calbindin-immunopositive (Calb) and
other neurons that were retrogradely labeled with cholera toxin sub-
unit b (CT) from the prefrontal cortex were mapped in a represen-
tative case. Calb/CT neurons (squares) and Calb/CT neurons
(crosses) are codistributed throughout the BF. Darkly retrogradely
labeled cells (CT, solid symbols and thick crosses) are distin-
guished from lightly retrogradely labeled cells (CT, open symbols
and thin crosses). Each symbol marks one labeled cell. For abbrevia-
tions, see Abbreviations list.
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Fig. 8. Computer-based atlas figures of the basal forebrain (BF)
cholinergic cell area on which parvalbumin-immunopositive (Parv)
and other neurons that were retrogradely labeled with cholera toxin
subunit b (CT) from the parietal cortex were mapped in a represen-
tative case. Parv/CT neurons (triangles) and Parv/CT neurons
(crosses) are codistributed throughout the BF. Darkly retrogradely
labeled cells (CT, solid symbols and thick crosses) are distin-
guished from lightly retrogradely labeled cells (CT, open symbols
and thin crosses). Each symbol marks one labeled cell. For abbrevia-
tions, see Abbreviations list.
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Fig. 9. Computer-based atlas figures of the basal forebrain (BF)
cholinergic cell area on which calbindin-immunopositive (Calb) and
other neurons that were retrogradely labeled with cholera toxin sub-
unit b (CT) from the parietal cortex were mapped in a representative
case. Calb/CT neurons (squares) and Calb/CT neurons (crosses)
are codistributed throughout the BF. Darkly retrogradely labeled
cells (CT, solid symbols and thick crosses) are distinguished from
lightly retrogradely labeled cells (CT, open symbols and thin crosses).
Each symbol marks one labeled cell. For abbreviations, see Abbrevi-
ations list.
25PARVALBUMIN, CALBINDIN, OR CALRETININ
detected in the Parv-CT than in the Calb-CT dual-
immunostained series, possibly suggesting a different sen-
sitivity in CT immunostaining depending on the anti-
bodies used in the sequential dual immunostaining.
Proportions of retrogradely labeled cells that were Parv
or Calb were calculated for individual series (Table 1).
Similar relative proportions of these cell groups were
found when considering only the darkly retrogradely la-
beled cells in the BF. From the prefrontal cortex, Parv/
CT neurons represented on average 38% and Calb/
CT neurons represented 36% of the cortically
projecting cells. Taken together, Parv/CT and Calb/
CT cells did not account for 100% of BF CT cells that
were retrogradely labeled from the prefrontal cortex (Ta-
ble 1). From the parietal cortex, the average proportion of
Parv/CT cells was 44% and that of the Calb/CT
cells was34% (Table 1). Altogether, they did not account
for 100% of BF CT cells that were retrogradely labeled
from the parietal cortex (Table 1). For the prefrontal and
parietal cortexes, the combined numbers and proportions
of Parv/CT and Calb/CT cells greatly exceeded those
previously estimated for GAD/CT cells, which repre-
sented 31–37% of CT cells labeled from the same cor-
tical areas (Gritti et al., 1997). They also somewhat ex-
ceeded the combined numbers and proportions of GAD/
CT and ChAT/CT cells, which represented 20–27%
(Gritti et al., 1997).
Colocalization of CBPs with GAD,
ChAT, or PAG
To determine whether the CBPs are colocalized with the
synthetic enzymes for the neurotransmitters GABA, ace-
tylcholine, or possibly glutamate in BF neurons, dual im-
munostaining was performed with immunohistofluores-
cence for the CBPs and EPs. Dual immunostaining was
assessed in individual CBP cells across the entire popu-
lation through the BF nuclei, except cells in the olfactory
tubercle (Table 2).
In sections dually immunostained for CBPs and GAD, a
very large number (90%) of Parv neurons was GAD
(Fig. 10A,B; Table 2). In contrast, a very small number
(5%) of Calb neurons was GAD (Fig. 10E,F; Table 2).
Similarly, a very small number (10%) of Calret neurons
was GAD (Fig. 10I,J; Table 2).
In sections dually immunostained for Calb and ChAT,
no Calb neurons were ChAT (not shown).
In sections dually immunostained for CBPs and the
synthetic enzyme for the transmitter glutamate, PAG, a
proportion (50%) of Parv cells was PAG (Fig. 10C,D;
Table 2). Slightly less than half (45%) of Calb neurons
was PAG (Fig. 10G,H; Table 2). Most Calret (85%)
neurons were PAG (Fig. 10K,L; Table 2).
DISCUSSION
The present immunohistochemical results revealed that
within the BF cholinergic cell area of the rat, neurons
containing the CBPs Parv, Calb, and Calret are diverse in
size and shape and distributed in a manner overlapping
with the GABAergic neurons, but they are greater in
number than the GABAergic cells therein. Parv and
Calb neurons were retrogradely labeled from the cere-
bral cortex, like GABAergic and cholinergic neurons, but
they were also larger in number than the GABAergic
projection neurons. These results indicated that CBP
neurons might comprise GABAergic and non-GABAergic
neurons in the BF. Dual immunostaining for the CBPs
and transmitter enzymes showed that, whereas the vast
majority of Parv neurons contains GAD, the vast major-
ity of Calb and Calret neurons does not. They appeared
to contain PAG in significant proportions, which is the
enzyme for the synthesis of transmitter glutamate. Ac-
cordingly, caudally or locally projecting neurons would
include Calret, possibly glutamatergic, neurons, and the
basal cortical projection neurons would be comprised prin-
cipally of Parv, likely GABAergic, neurons and Calb,
possibly glutamatergic, neurons in addition to CBP cho-
linergic neurons.
Methodologic considerations
The initial aim of the present study was to determine
whether subgroups of GABAergic neurons contain different
CBPs that would allow their subsequent differentiation and
identification. The findings in immunoperoxidase-stained
material indicated that estimated numbers of CBP-
containing neurons greatly exceeded previously estimated
numbers of GAD cells. To permit this comparison, we
plotted cell profiles with the aid of the same two-
dimensional image analysis system and estimated cell
numbers with the same method (Abercrombie, 1946) used
in our original work for estimating GAD and ChAT
cells in delineated nuclei of the BF (Gritti et al., 1993,
1994, 1997). Although such methods are increasingly be-
ing replaced by three-dimensional stereologic counting
techniques (Coggeshall and Lekan, 1996), they nonethe-
less allow approximate estimates of cell numbers and are
deemed appropriate when they are employed as in the
present study for comparison with data obtained in the
same manner (Guillery and Herrup, 1997). This compar-
ison indicated that the combined numbers of the CBP
cell groups greatly exceeded the number of GAD cells
and that the combined proportions of cortically projecting
CBP cell groups greatly exceeded that of the cortically
projecting GAD cells. Given these results, we examined
in dual-immunofluorescent stained material whether
TABLE 2. Calcium Binding Protein Immunopositive Neurons in Immunofluorescent Material That Were Dual Immunopositive
for GAD or PAG in the Basal Forebrain1
Cell type
% CBP % CBP
CBP CBP/GAD (CBP/GAD) CBP CBP/PAG (CBP/PAG)
Parv 98.7 
 3.8 90.0 
 5.0 91.2 58 
 1.7 30.0 
 1.0 51.7
Calb 122.7 
 16.9 5.3 
 0.6 4.4 83.3 
 1.5 37.3 
 3.5 44.8
Calret 158.8 
 14.4 13.0 
 1.0 8.2 110.0 
 3.6 95.7 
 5.8 86.9
1The number of CBP neurons (mean
 standard deviation) examined across basal forebrain nuclei (except the olfactory tubercle) and the number of those that were double labeled
for GAD (CBP/GAD) or PAG (CBP/PAG) are presented with the average percentage of each cell type that was double labeled (based on three dual-immunostained series per
CBP from CT80, CT81, CT82, CT83, PP1 or PP2). , Immunopositive; Calb, calbindin; Calret, calretinin; CBP, calcium binding protein; GAD, glutamic acid decarboxylase; PAG,
phosphate activated glutaminase; Parv, parvalbumin.
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CBP cells were also immunopositive for GAD, ChAT, or
PAG. In this examination by fluorescence microscopy,
which did not allow processing by our image analysis
system, we made no attempt to estimate cell numbers but
simply calculated the proportions of double-labeled cell
profiles, thereby permitting an estimation of the propor-
tion of CBP cells with the capacity to synthesize GABA,
acetylcholine, or glutamate, as discussed below.
Distribution of CBP-containing neurons
Parv, Calb, and Calret neurons varied in shape and
size in the BF, as found by others in the medial septum–
diagonal band nuclei (Kiss et al., 1990b, 1997), magnocel-
lular basal nuclei (Celio, 1990; Chang and Kuo, 1991), and
other forebrain structures (Freund and Buzsaki, 1996;
DeFelipe, 1997; McDonald and Betette, 2001). Of the
three groups of CPB-containing cells in the BF, the Parv
neurons appeared to be the largest and most homogeneous
in cell size, thus most closely resembling the prominent,
magnocellular GAD cells in the BF (Gritti et al., 1993).
The CBP cell groups, like GAD cells, are distributed
coextensively with cholinergic cells throughout the BF,
thus substantiating reports by others of this distribution
in the medial septum–diagonal band (Kiss et al., 1990b,
1997) and magnocellular basal nuclei of the rat (Celio,
1990; Chang and Kuo, 1991; Smith et al., 1994; Zaborszky
et al., 1999). Whereas the distribution of the Parv cells
resembled that of the large GAD cells, that of Calb and
Calret cells could not be simply likened to that of partic-
ular GAD cells.
The total number of CBP neurons (estimated at
117,000) across the BF greatly exceeded that of the
GAD neurons (39,000; Gritti et al., 1993). A larger
number of CBP cells than of GAD cells in the BF was
noted by Zaborszky et al. (1999) and interpreted by them
to mean that the number of GAD cells had been previ-
ously underestimated by us. It appeared more probable to
us that neurons in addition to GAD neurons might be
immunostained for CBPs, in particular for Calb and Cal-
ret. It was thus considered possible that Calb, contained in
the largest number of cells, could also be contained in
cholinergic neurons in the rat brain, as found in the mon-
key brain, despite claims to the contrary (Chang and Kuo,
1991; Ichitani et al., 1993). Given that the total number of
CBP neurons actually exceeded the total number of
GAD and ChAT neurons across the BF, it also appeared
possible that other non-GABAergic and non-cholinergic
neurons could contain CBPs.
Distribution and number of cortically
projecting CBP-containing neurons
Parv, Calb, and Calret neurons were retrogradely
labeled from the cerebral cortex, and Parv and Calb
neurons were labeled in substantial numbers and thus
Fig. 10. Photomicrographs of sections through the basal forebrain
(magnocellular preoptic nucleus) showing dual-immunofluorescent
staining (using Cy2- and Cy3-conjugated secondary antibodies, in
green and red, respectively) to reveal colocalization of the calcium
binding proteins (CBPs; green) with enzyme proteins (EPs; red), glu-
tamic acid decarboxylase (GAD; left panels) or phosphate activated
glutaminase (PAG; right panels). CBP-immunostained cells are indi-
cated by solid arrowheads, and EP immunostaining of the same neu-
rons is indicated by solid arrowheads for EP neurons and open
arrowheads for EP neurons. Dual immunostaining for parvalbumin
(Parv) and GAD (A, B) or Parv-PAG (C, D) revealed that most Parv
neurons (solid arrowheads in A) were GAD (solid arrowheads in B)
and some Parv neurons (solid arrowhead in C) were PAG (open
arrowhead in D). In sections dual immunostained for calbindin (Calb)
and GAD (E, F) or Calb-PAG (G, H), most Calb neurons (solid
arrowheads in E) were GAD (open arrowheads in F) and many Calb
neurons (solid arrowheads in G) were PAG (solid arrowheads in H).
In sections dual immunostained for calretinin (Calret) and GAD (I, J)
or Calret-PAG (K, L), most Calret cells (solid arrowheads in I) were
GAD (open arrowheads in J) and some Calret cells (solid arrow-
heads in K) were PAG (solid arrowhead in L). Scale bar  20 m.
27PARVALBUMIN, CALBINDIN, OR CALRETININ
potentially representing the GABAergic cortically project-
ing cell group, in contrast to Calret neurons, which were
retrogradely labeled in numbers considered too small to
pursue systematically. It was also apparent in different
dual-immunostained series that different numbers of ret-
rogradely labeled cells were apparent, suggesting a differ-
ential sensitivity in the dual immunostaining for reasons
of antibody competition and/or displacement. Accordingly,
total numbers of retrogradely labeled neurons differed
between the Parv-CT and Calb-CT series of sections,
which were thus considered independently for the calcu-
lation of proportions of retrogradely labeled cells. How-
ever, we cannot be sure that these proportions were not
biased by the different sensitivities and thus should be
considered as estimates. We also noted, as described pre-
viously, that, of the total population of retrogradely la-
beled cells, many were lightly retrogradely labeled with
CT (Gritti et al., 1997), which is a very sensitive retro-
grade tracer. To be sure that the proportions of retro-
gradely cells calculated from the total numbers were not
determined by a different density of retrograde labeling
and thus projection, we also checked the proportions of the
darkly retrogradely labeled cells. As established previ-
ously for the GAD and ChAT cells, the relative propor-
tions did not change when comparing groups of darkly
retrogradely labeled CBP cells. We interpreted these
results to indicate that, like the GAD and ChAT cells,
the Parv and Calb cell groups comprise substantial
proportions of cortically projecting neurons that provide a
dense terminal innervation to a focused cortical target
area in addition to a potentially more dispersed innerva-
tion to surrounding areas.
Although they varied to some degree in size and shape,
Parv, Calb, and even the Calret cortically projecting
cells, like the GABAergic and cholinergic cortically pro-
jecting cells of the BF, were generally medium to large in
size. Despite differences attributed to variations in injec-
tion site and sensitivity of dual-immunostaining, retro-
gradely labeled Parv cells and Calb cells were approx-
imately similarly distributed through the nuclei of the BF
from the medial septum to the globus pallidus and over-
lapped in their distribution with that of GABAergic and
cholinergic neurons of the BF projecting to the prefrontal
and parietal cortexes (Gritti et al., 1997).
Through the medial septum to the globus pallidus,
Parv cortically projecting cells were present in substan-
tial numbers, representing an average of 40–45% of the
cortically projecting cells across the BF. This proportion
was similar to, albeit greater than, that of the GAD
cortically projecting neurons (30–37%), as calculated in
our previous study (Gritti et al., 1997). The results indi-
cated that the Parv cells could account for the
GABAergic cortically projecting neurons of the BF. A sim-
ilar conclusion was reached for the GABAergic neurons in
the medial septum–diagonal band nuclei projecting to the
hippocampus (Freund, 1989). Calb cortically projecting
cells also were present throughout the BF and accounted
for 35% of cortically projecting neurons. These results
were at odds with those of Smith et al. (1994) who did not
find retrograde labeling of Calb cells in the BF. In view of
our findings, such a negative result is surprising. It may
be attributed to a lower sensitivity of the retrograde tracer
(fluorogold) used or of the dual immunostaining for that
tracer with Calb, which we also found to be less sensitive
than that for CT-Parv. Given that the proportions of
Calb and Parv retrogradely labeled cells were 30–
45%, it appeared that both could not correspond to the
cortically projecting GABAergic cells or that Calb and
Parv could be colocalized in the same magnocellular
GABAergic neurons. This possibility cannot be ruled out
because such colocalization has been documented in the
amygdala (McDonald and Betette, 2001; McDonald and
Mascagni, 2001). The Calret seen in a small number of
retrogradely labeled cells also could be colocalized in the
same cells, given evidence for colocalization of the three
CBPs in neurons within certain forebrain regions
(Wouterlood et al., 2000). However, such colocalization
appears less likely in the BF neurons because it is rela-
tively rare in other forebrain structures (Gulyas et al.,
1991; Kubota et al., 1993; DeFelipe, 1997) and not at all
within the medial septum–diagonal band nuclei (Kiss et
al., 1997). Thus, Parv, Calb, and Calret cortically pro-
jecting neurons likely corresponded predominantly to dis-
tinct cell subgroups and that those subgroups might not be
all GABAergic.
Colocalization of CBP with ChAT,
GAD, or PAG in the BF
Given the high degree of colocalization of Parv, Calb,
and Calret with GAD or GABA in the neocortex, hip-
pocampus, and the neostriatum (Kubota et al., 1993;
Freund and Buzsaki, 1996; DeFelipe, 1997), we expected
that such colocalization would also be frequent in the BF.
Although this was the case for Parv, it was not for Calb or
Calret. Of the Parv cells throughout the BF, more than
90% were dual immunostained for GAD in the present
study, indicating that the vast majority of Parv cells has
the capacity to synthesize GABA. In previous studies us-
ing dual immunostaining of anterogradely labeled septo-
hippocampal fibers and terminals, it was believed that the
Parv fibers emerging from the septum–diagonal band
neurons contained GABA (Freund, 1989) and that the
Parv neurons thus corresponded to the GABAergic sep-
tohippocampal projection neurons. Our present transmit-
ter enzyme immunohistochemical and retrograde trans-
port results also indicated that the Parv BF neurons
have the capacity to synthesize GABA and appear to cor-
respond in large part to the basal cortical GABAergic
projection neurons. In contrast, few Calb cells (5%)
contained GAD. Such minimal colocalization of Calb with
GAD had been noted in the magnocellular basal nucleus
(Smith et al., 1994). We also confirmed that Calb neurons
do not colocalize ChAT in the rat brain, although they had
been found to do so in the primate brain (Chang and Kuo,
1991; Smith et al., 1994). We thus concluded from our
retrograde and transmitter enzyme immunohistochemical
results that Calb is predominantly contained within a
distinct group of non-GABAergic, non-cholinergic basal
cortical projection neurons. Like Calb cells, few Calret
cells (10%) contained GAD, leading us to conclude that
Calret is contained predominantly in a distinct subgroup
of non-cholinergic, non-GABAergic, caudally or locally
projecting BF neurons.
Having recently established that the enzyme used in the
synthesis of the transmitter glutamate, PAG, is localized
in BF cortically projecting neurons (Manns et al., 2001),
we sought to establish whether this enzyme was contained
in the different CBP cell groups. In studies within the
neocortex, where all CBP neurons also contained GAD,
none contained PAG (Kaneko et al., 1992). The situation
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was different in the present study. Approximately half of
the Parv cells was also immunopositive for PAG, indicat-
ing that a proportion of these cells may have the potential
to synthesize glutamate as a neurotransmitter. For GAD
neurons, a similar proportion was found to contain PAG,
indicating that, as in other areas of the brain, some BF
neurons may have the capacity to synthesize GABA and
glutamate (as discussed by Manns et al., 2001). Whether
such cells use glutamate as a neurotransmitter can be
determined only by immunostaining for the glutamate
vesicular transporter proteins, which are evident in nerve
terminals but not in cell bodies (Fremeau et al., 2001; B.E.
Jones, unpublished observations). Among all Calb cells,
slightly less than half was immunopositive for PAG, indi-
cating that a significant proportion of these cells have the
capacity to synthesize glutamate as a neurotransmitter.
Because most cortically projecting neurons were found to
be PAG (Manns et al., 2001), we concluded that the
Calb cortically projecting neurons most probably contain
this enzyme and are thus potentially glutamatergic. Such
cells may parallel in their projections and actions the
Calb glutamatergic neurons of the thalamus (Frassoni et
al., 1997), which provide a widespread projection to the
superficial layers of the cerebral cortex (Rausell and
Jones, 1991; Jones, 1998). The vast majority of Calret
neurons was immunopositive for PAG and not retro-
gradely labeled from the cortex, thus likely corresponding
to glutamatergic neurons with caudally or locally directed
projections. Such a possibility has been considered in the
piriform and entorhinal cortex, where, in addition to con-
taining glutamate, Calret cells were found to provide
asymmetric, and thus excitatory, synapses to local cortical
neurons (Frassoni et al., 1998; Wouterlood et al., 2000).
Functional significance of CBP content
in BF cell groups
In the hippocampus and neocortex, neurons containing
the CBPs, which are commonly GABAergic interneurons,
have been distinguished in their electrophysiologic prop-
erties from those lacking CBPs, i.e., the pyramidal neu-
rons, by their frequently continuous and fast spiking dis-
charge (Celio, 1986; Kawaguchi et al., 1987; Kawaguchi
and Hama, 1988; Kawaguchi and Kubota, 1993; Freund
and Buzsaki, 1996). Indeed, the CBPs serve to buffer Ca2
and accordingly prevent Ca2-activated K currents from
hyperpolarizing the membrane and inhibiting spike gen-
eration (Baimbridge et al., 1992). CBPs accordingly can
also shape discharge patterns and in their absence or
paucity permit phasic discharge by neurons (Li et al.,
1995). Throughout the forebrain, Parv neurons are com-
monly fast spiking cells, as evident from in vitro and in
vivo recording studies of identified neurons (Celio, 1986;
Kawaguchi et al., 1987; Kawaguchi, 1993; Kawaguchi and
Kubota, 1993; Sik et al., 1995). In the medial septum–
diagonal band, Parv cells have been found to be fast
spiking by in vitro recordings (Morris et al., 1999) and in
the BF (in one cell) by in vivo recordings (Duque et al.,
2000). In our in vivo recording studies, we identified a
large number of cortically projecting GAD neurons that
discharge tonically at relatively high rates (average  30
Hz) in association with cortical activation (Manns et al.,
2000a) and thus could correspond to the cortically project-
ing, Parv BF neurons identified here. ChAT cells that
do not contain the CBPs in the rat brain (Kiss et al.,
1990b, 1997; Smith et al., 1994) discharge in a slow tonic
manner and in a phasic bursting manner in association
with cortical activation (Manns et al., 2000b). Other cor-
tically projecting BF neurons that were GAD and pre-
sumed noncholinergic cells discharged tonically at a mod-
erate rate and may correspond to Calb neurons (Manns
et al., 2000a), which in other forebrain areas have been
shown to discharge tonically (Li et al., 1995). Conversely,
in the neocortex and hippocampus, Calb neurons dis-
played phasic discharge properties in addition to fast spik-
ing (Kawaguchi and Kubota, 1993; Sik et al., 1995; Freund
and Buzsaki, 1996). Thus, recently discovered GAD,
ChAT, PAG cortically projecting BF neurons that were
found to discharge at a moderate rate (average  20 Hz)
and to discharge in a phasic manner in association with
cortical activation (Manns et al., 2000c) could also be
Calb cells.
CBPs also have the capacity to prevent or attenuate
damage to cells due to excessive entry of Ca2 during
intense activity (Scharfman and Schwartzkroin, 1989).
Such protection has been thought to underlie the selective
survival and, conversely, selective vulnerability of neu-
rons containing or lacking the different CBPs (for review,
see Morrison et al., 1998). Given that Parv and Calret
neurons appear the most resistant and Calb neurons the
least among CBP-containing neurons in the cortex of pa-
tients with Alzheimer’s disease, it is also possible that
similarly different degrees of resistance would apply to BF
neurons. Thus, Parv GABAergic cortically projecting and
Calret caudally or locally projecting neurons, docu-
mented here in the rat brain, might be expected to be more
resistant than the Calb-containing cholinergic neurons in
the human brain (Ichimiya et al., 1989) and other Calb
potentially glutamatergic cortically projecting neurons
therein.
Before gleaning more precise knowledge concerning the
discharge properties and vulnerability to damage of the
specific CBP-containing BF cell groups, the present re-
sults provide important information concerning the exis-
tence of noncholinergic, non-GABAergic basal cortical pro-
jection neurons and an immunohistochemical means of
identifying them. From these results, it can be concluded
that the basal cortical projection comprises, in addition to
cholinergic neurons, likely GABAergic Parv and possibly
glutamatergic Calb neurons. The existence of these non-
cholinergic basal cortical projection neurons may explain
the finding that selective lesions of cholinergic neurons
alone do not produce the serious attention and memory, as
well as electroencephalographic, deficits of nonselective
lesions of the entire BF cell population do in the rat
(Dunnett et al., 1991; Lee et al., 1994; Voytko et al., 1994;
Baxter et al., 1995). Accordingly, in addition to cholinergic
and likely GABAergic Parv neurons, possibly glutama-
tergic Calb basal cortical projection neurons may play a
critical role in modulating cortical activity and facilitating
arousal, attention, and memory, functions that are greatly
compromised with the degenerative changes occurring in
the BF with Alzheimer’s disease.
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